Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2021-05-15
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
ABG+/GarlACE Effects on Cardiovascular Risk Factors in Subjects With Grade I Hypertension
NCT06264622
Efficacy of a Natural Ingredient on Blood Pressure
NCT03471533
Prehypertension and Dietary Supplements - The PYRAMIDS Study
NCT01682291
Effect of NO Precursors on Physiological Responses to Exercise
NCT02850367
Effect of Nitrate Supplementation on Blood Pressure and Microvascular Function of Resistant Hypertensive Patients
NCT06169241
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ABG Black Garlic Extract
Daily intake of a 550 mg tablet, containing 250 mg of Black Garlic Extract and 300 mg of excipients.
ABG+ Black Garlin
Daily tablet intake during three months
Placebo
Daily intake of a 550 mg tablet, containing 250 mg of microcrystalline cellulose and 300 mg of excipients
Crystalline Cellulose
Daily tablet intake during three months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ABG+ Black Garlin
Daily tablet intake during three months
Crystalline Cellulose
Daily tablet intake during three months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Fasting blood cholesterol levels below 115 mg/dL
* Fasting blood glucose levels above 126 mg/dL
* Taking anyone of the Angiotensin-converting enzyme inhibitors
* Anemia (hemoglobin below 13 g/dL in men and below 12 g/dL in women)
* Vitamin or nutraceutical intake in the last 30 days before the study enrollment
* Chronic gastrointestinal diseases
* Pregnancy and breastfeeding
* Garlic allergy
* Participation in another study 30 days before the study enrollment
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pharmactive, S.L.
UNKNOWN
Universitat de Lleida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
José Serrano
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manuel S Portero, PhD
Role: PRINCIPAL_INVESTIGATOR
Universitat de Lleida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Arnau de Vilanova
Lleida, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CEIC-2435
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.